Fig. 8From: Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cellsMTT results of DHQ3 and 17-DR on ten human cancer cell lines. HepG2, SMMC7721, MCF-7, MDA-MB-231, T-47D,CNE-2Z, HNE1, A549, SGC7901, ISK, SW480 were exposed to 200 μM analogs as in previous experiments with MDA-MB-231 cells for 24 h, with or without pre-treatment with Nec-1. The cell survival rates were assessed using MTT assays. *P < 0.05Back to article page